CSIMarket
 

Healthcare Sector

Biotechnology & Pharmaceuticals Industry Growth  


Growth Rates by Company within Biotechnology & Pharmaceuticals Industry




Revenue Growth Net Income Growth
Company Quarter Y / Y Sequential Y / Y Sequential
Abcam Plc 4Q 2022 - - - -
Acumen Pharmaceuticals Inc 4Q 2023 - - - -
Atlantic Coastal Acquisition Corp Ii 4Q 2023 - - - -
Aceragen Inc 1Q 2023 - down -48.68 % - -
Achilles Therapeutics Plc 4Q 2022 - - - -
Arcellx Inc 3Q 2023 - up 4.58 % - -
Acorda Therapeutics Inc 3Q 2023 down-17.3 % down -6.6 % - -
Adaptimmune Therapeutics Plc 4Q 2023 down-84.18 % down -80.7 % - -
Adma Biologics Inc 4Q 2023 up 49.43 % up 12.05 % - -
Adaptive Biotechnologies Corporation 3Q 2023 down-20.72 % down -22.5 % - -
Adverum Biotechnologies Inc 4Q 2023 - - - -
Aerie Pharmaceuticals Inc 3Q 2022 up 23.25 % up 8.46 % - -
Agenus Inc 3Q 2023 up 6.77 % down -3.88 % - -
Applied Genetic Technologies Corporation 3Q 2022 - - - -
Aim Immunotech Inc 2Q 2022 up 30.43 % down -9.09 % - -
Avalon Globocare Corp 3Q 2023 up 4.38 % up 7.95 % - -
Alector Inc 3Q 2023 down-38.67 % down -83.8 % - -
Aligos Therapeutics Inc 3Q 2023 down-21.12 % down -52.96 % - -
Allogene Therapeutics inc 4Q 2022 - - - -
Allena Pharmaceuticals Inc. 2Q 2022 - - - -
Alvotech 4Q 2023 - - - -
Allovir Inc 3Q 2023 - - - -
Ambrx Biopharma Inc 3Q 2023 down-99.29 % down -95.28 % - -
Amgen Inc 4Q 2023 up 19.84 % up 18.73 % down -52.54 % down -55.66 %
Apogee Therapeutics inc 3Q 2023 - - - -
Apeiron Capital Investment Corp 1Q 2022 - - - up 165407.42 %
Aptose Biosciences Inc 3Q 2023 - - - -
Argenx se 4Q 2023 up 191.46 % up 191.46 % - -
Armata Pharmaceuticals Inc 4Q 2023 up 45.39 % up 24.73 % - -
Athira Pharma Inc 3Q 2023 - - - -
Atara Biotherapeutics Inc 3Q 2023 up 23.21 % up 52.23 % - -
Aura Biosciences Inc 3Q 2023 - - - -
Autolus Therapeutics Plc 3Q 2023 - - - -
Avrobio Inc 3Q 2023 - - - -
Anavex Life Sciences Corp 4Q 2023 down-21.96 % down -11.63 % - -
Axcella Health Inc 2Q 2023 - - - -
Old Ayala Inc 4Q 2022 down-90.84 % up 15.38 % - -
Bioatla Inc 3Q 2023 - - - -
Biocardia Inc 4Q 2023 down-87.74 % down -96.36 % - -
Brainstorm Cell Therapeutics Inc 4Q 2023 - - - -
Biocryst Pharmaceuticals Inc 4Q 2023 up 17.42 % up 7.68 % - -
Black Diamond Therapeutics Inc 4Q 2023 - - - -
Beam Therapeutics Inc 3Q 2023 up 8.82 % down -14.53 % - -
Biogen Inc 4Q 2023 down-6.2 % down -5.69 % down -54.7 % -
Bluebird Bio Inc 3Q 2023 up 17353.52 % up 79.85 % - -
Biontech Se 4Q 2023 - - down -90.14 % down -90.14 %
Zeo Scientifix Inc 4Q 2023 up 7.83 % down -18.84 % - -
Biondvax Pharmaceuticals Ltd 4Q 2022 - - - -
Cabaletta Bio Inc 3Q 2023 - - - -
Candel Therapeutics Inc 3Q 2023 - - - -
Cannabis Global Inc. 2Q 2022 up 2969.44 % up 26.3 % - -
C4 Therapeutics Inc 4Q 2023 up 14.26 % down -70.55 % - -
Codiak Biosciences Inc 3Q 2022 down-54.88 % down -96.03 % - -
Cidara Therapeutics Inc 3Q 2023 - up 67.03 % - -
Creative Medical Technology Holdings Inc 4Q 2023 down-83.87 % down -50 % - -
Cullinan Oncology Inc 3Q 2023 - - - -
Compugen Ltd 4Q 2022 up 25 % - - -
Cognition Therapeutics inc 4Q 2023 - - - -
Chromocell Therapeutics Corporation 4Q 2023 - - - -
Coherus Biosciences inc 4Q 2023 up 101.81 % up 22.74 % - -
Calidi Biotherapeutics Inc 4Q 2023 - - - -
Checkmate Pharmaceuticals Inc 1Q 2022 - - - -
Compass Therapeutics Inc 4Q 2023 - - - -
Coeptis Therapeutics Holdings Inc 4Q 2022 - - - -
Caribou Biosciences Inc 4Q 2023 down-3.63 % down -84.96 % - -
Cardiff Oncology inc 3Q 2023 up 119.42 % up 4.13 % - -
Cardiol Therapeutics inc 4Q 2023 - - - -
Cargo Therapeutics Inc 3Q 2023 - - - -
Curis Inc 4Q 2023 down-6.62 % down -4.84 % - -
Crispr Therapeutics Ag 3Q 2023 - - - -
Clarus Therapeutics Holdings Inc. 2Q 2022 - up 0.97 % - -
Champions Oncology Inc 4Q 2023 down-5.9 % up 3.85 % - -
Cel sci Corporation 4Q 2023 - - - -
Cyclo Therapeutics Inc 4Q 2023 up 66.7 % down -37.15 % - -
Dbv Technologies S a 4Q 2023 - up 274.11 % - -
Ginkgo Bioworks Holdings Inc 3Q 2023 down-16.52 % down -31.2 % - -
Denali Therapeutics Inc 4Q 2023 - - - -
Precision Biosciences Inc 3Q 2023 up 78.19 % down -33.7 % - -
Dyadic International Inc 4Q 2023 - up 72.9 % - -
Editas Medicine Inc 4Q 2023 up 818.6 % up 1025.36 % - -
Eiger Biopharmaceuticals Inc 4Q 2023 up 41.06 % up 18.51 % - -
Elevation Oncology inc 4Q 2023 - - - -
Eloxx Pharmaceuticals Inc 3Q 2023 - - - -
Elutia inc 4Q 2023 down-48.44 % up 11.8 % - -
Entera Bio Ltd 4Q 2023 - - - down -16.14 %
Enzon Pharmaceuticals inc 4Q 2023 up 2357.69 % up 2.73 % up 101.8 % up 109.35 %
Erytech Pharma S a 4Q 2022 - - - -
Estrella Immunopharma Inc 4Q 2023 - - - -
Evaxion Biotech A 4Q 2023 - - - -
Exelixis Inc 4Q 2023 up 13.15 % up 1.64 % - up 2649.05 %
Fate Therapeutics Inc 3Q 2023 down-87.02 % up 108.36 % - -
4d Molecular Therapeutics Inc 3Q 2023 up 3940.8 % up 8353.56 % - -
Fennec Pharmaceuticals inc 4Q 2023 - - - -
Forma Therapeutics Holdings Inc. 2Q 2022 - - - -
Finch Therapeutics Group Inc 3Q 2023 - - - -
Freeline Therapeutics Holdings Plc 4Q 2022 - - - -
Fresh Tracks Therapeutics Inc 4Q 2023 - - - -
Fusion Pharmaceuticals Inc 3Q 2023 up 1108.43 % up 5800 % - -
Agentix Corp 4Q 2023 - - - -
Gilead Sciences Inc 4Q 2023 down-3.72 % up 0.89 % down -13.23 % down -34.76 %
Monte Rosa Therapeutics Inc 3Q 2023 - - - -
Gamida Cell Ltd 3Q 2023 - - down -91.47 % -
Genocea Biosciences Inc 1Q 2022 down-68.38 % down -30.23 % - -
Genfit S a 4Q 2023 up 43.7 % up 43.7 % - -
Genenta Science S p a 4Q 2023 - - - -
Green Planet Bioengineering Co Ltd 4Q 2023 - - - -
Greenlight Biosciences Holdings Pbc 1Q 2023 up 1386.38 % up 26.36 % - -
Graphite Bio Inc 3Q 2023 - - - -
Gritstone Bio Inc 3Q 2023 down-48.2 % down -19.95 % - -
Halozyme Therapeutics Inc 4Q 2023 up 26.75 % up 6.48 % up 47.98 % up 4.34 %
Hillevax Inc 3Q 2023 - - - -
Humacyte Inc 4Q 2023 - - - -
Immunitybio inc 4Q 2023 up 90.41 % up 69.51 % - -
Icosavax Inc 3Q 2023 - - - -
Ikena Oncology Inc 3Q 2023 down-81.49 % down -40.87 % - -
Inhibikase Therapeutics Inc 3Q 2023 up 991.33 % down -31.65 % - -
Immunocore Holdings Plc 4Q 2023 - - - -
Immunovant Inc 4Q 2023 - - - -
In8bio Inc 3Q 2023 - - - -
Inhibrx Inc 4Q 2023 up 496.35 % up 1273.11 % - -
Mink Therapeutics Inc 3Q 2023 - - - -
Inmune Bio Inc 3Q 2023 down-56.12 % down -6.52 % - -
Intensity Therapeutics Inc 3Q 2023 - - - -
Iovance Biotherapeutics Inc 4Q 2023 - up 2.77 % - -
Innate Pharma Sa 4Q 2023 up 6.88 % up 6.88 % - -
Century Therapeutics inc 4Q 2023 down-48.56 % up 81.08 % - -
Iteos Therapeutics Inc 3Q 2023 - - - -
Invivyd Inc 3Q 2023 - - - -
Jounce Therapeutics inc 4Q 2022 - - - -
Jasper Therapeutics Inc 3Q 2023 - - - -
Kodiak Sciences Inc 3Q 2023 - - - -
Kiromic Biopharma Inc 4Q 2023 - - - -
Krystal Biotech Inc 4Q 2023 - up 392.55 % - down -89.24 %
Kymera Therapeutics Inc 1Q 2022 - down -52.68 % - -
Ladrx Corporation 4Q 2023 - - - -
Lineage Cell Therapeutics Inc 3Q 2023 down-58.44 % down -61.36 % - -
Semper Paratus Acquisition Corporation 3Q 2023 - - - -
Atyr Pharma Inc 3Q 2023 - - - -
La Jolla Pharmaceutical Company 2Q 2022 down-34.35 % up 1.13 % down -34.15 % up 122800 %
Logicbio Therapeutics Inc 3Q 2022 up 28.16 % down -15.07 % - -
Lexeo Therapeutics Inc 3Q 2023 - - - -
Mesoblast Ltd 2Q 2023 down-26.56 % down -26.56 % - -
Meiragtx Holdings Plc 4Q 2023 - down -60.02 % - -
Miromatrix Medical inc 3Q 2023 down-9.83 % up 31.22 % - -
Molecular Partners Ag 4Q 2023 down-96.29 % down -96.29 % - -
Moderna Inc 4Q 2023 down-44.71 % up 53.52 % down -85.19 % -
Mymetics Corporation 3Q 2023 down-73.85 % down -81.62 % - -
Neurocrine Biosciences Inc 4Q 2023 up 25.05 % up 3.29 % up 65.96 % up 77.74 %
Nkgen Biotech Inc 4Q 2023 - - - -
Neumora Therapeutics Inc 3Q 2023 - - - -
Nanostring Technologies Inc 3Q 2023 up 62.79 % up 8.9 % - -
Novavax inc 4Q 2023 down-18.48 % up 55.81 % - -
Ocugen Inc 4Q 2023 - - - -
Omega Therapeutics Inc 3Q 2023 up 39.66 % up 9.49 % - -
Organovo Holdings Inc 3Q 2023 - - - -
Opthea Limited 2Q 2023 up 58 % up 58 % - -
Orchard Therapeutics Plc 3Q 2023 up 9.09 % down -13.84 % - -
Outlook Therapeutics Inc 4Q 2023 - - - -
Oyster Point Pharma Inc 3Q 2022 down-68.84 % up 19.13 % - -
Palisade Bio Inc 3Q 2023 - - - -
Passage Bio inc 4Q 2023 - - - -
Phoenix Biotech Acquisition Corp 3Q 2023 - - - -
Point Of Care Nano technology Inc 1Q 2023 - - - -
Vaxcyte Inc 3Q 2023 - - - -
Biomx Inc 3Q 2023 - - up 16.61 % up 23.32 %
Peak Bio Inc 2Q 2023 - - - -
Pluri Inc 4Q 2023 up 5150 % up 94.44 % - -
Protalix Biotherapeutics inc 4Q 2023 up 21.69 % up 1.36 % - -
Pharmacyte Biotech Inc 4Q 2023 - - - -
Prime Medicine Inc 4Q 2023 - - - -
Prokidney Corp 3Q 2023 - - - -
Poseida Therapeutics Inc 3Q 2023 down-91.96 % down -53.27 % - -
Polarityte Inc 4Q 2022 - - - -
Mosaic Immunoengineering Inc 4Q 2023 - - - -
Qiagen N v 4Q 2023 down-8.67 % down -8.67 % down -19.35 % down -19.35 %
Qrons Inc 4Q 2023 - - - -
Renovacor Inc 3Q 2022 - - - -
Replicel Life Sciences Inc 4Q 2022 - - - -
Replimune Group Inc 4Q 2023 - - - -
Repligen Corp 3Q 2023 down-29.66 % down -11.29 % down -55.03 % down -9.43 %
Regenxbio Inc 3Q 2023 up 9.06 % up 44.74 % - -
Relay Therapeutics Inc 3Q 2023 up 7226.16 % up 21078.15 % - -
Rubius Therapeutics Inc 4Q 2022 - - - -
Revolution Medicines Inc 3Q 2023 - - - -
Redwoods Acquisition Corp 3Q 2023 - - down -52.71 % -
Recursion Pharmaceuticals Inc 4Q 2023 down-20.36 % up 3.4 % - -
Sab Biotherapeutics Inc 3Q 2023 down-64.69 % up 1381.98 % - -
Sana Biotechnology Inc 3Q 2023 - - - -
Scilex Holding Company 3Q 2023 - down -19.59 % - -
Seagen Inc 3Q 2023 up 27.11 % up 7.42 % - -
Sangamo Therapeutics Inc 4Q 2023 down-92.5 % down -78.27 % - -
Solid Biosciences Inc 3Q 2023 - - - -
Senti Biosciences Inc 3Q 2023 down-80.86 % down -63.93 % - -
Sophia Genetics Sa 4Q 2023 up 30.18 % up 30.18 % - -
Spk Acquisition Corp 3Q 2022 - - - -
Sqz Biotechnologies Company 3Q 2023 - - - -
Sorrento Therapeutics Inc 2Q 2023 up 31.1 % down -7.54 % - -
Scholar Rock Holding Corp 4Q 2023 - - - -
Surrozen Inc 3Q 2023 - - - -
Sutro Biopharma Inc 3Q 2023 down-32.7 % up 62.54 % - -
Surface Oncology Inc 2Q 2023 - - - -
Springworks Therapeutics Inc 4Q 2023 - - - -
Protara Therapeutics Inc 3Q 2023 - - - -
Tarsus Pharmaceuticals Inc 4Q 2023 up 30.76 % up 598.88 % - -
Tc Biopharm holdings Plc 4Q 2022 up 94.3 % up 94.3 % - -
Tracon Pharmaceuticals Inc 3Q 2023 - - - -
Tcr2 Therapeutics Inc 1Q 2023 - - - -
Tscan Therapeutics Inc 3Q 2023 up 15.58 % up 23.48 % - -
Bio techne Corp 4Q 2023 up 0.37 % down -1.3 % down -45.08 % down -46.14 %
Instil Bio Inc 3Q 2023 - - - -
Tenaya Therapeutics Inc 3Q 2023 - - - -
Tourmaline Bio Inc 4Q 2023 - - - -
Turnstone Biologics Corp 3Q 2023 - - - -
Taysha Gene Therapies Inc 3Q 2023 - up 98.16 % - -
Titan Pharmaceuticals Inc 4Q 2023 down-81.67 % down -98.73 % - -
Twist Bioscience Corporation 4Q 2023 up 31.81 % up 6.8 % - -
Valneva Se 4Q 2023 down-57.46 % down -57.46 % - -
Vericel Corporation 4Q 2023 up 23.35 % up 42.59 % up 119.4 % -
10x Capital Venture Acquisition Corp Iii 3Q 2023 - - - -
Vectivbio Holding Ag 4Q 2022 - - - -
Vigil Neuroscience Inc 3Q 2023 - - - -
Vir Biotechnology Inc 4Q 2023 down-66.03 % up 536.11 % - -
Vor Biopharma Inc 3Q 2023 - - - -
Vaxart Inc 4Q 2023 up 14650 % up 54.45 % - -
Voyager Therapeutics Inc 4Q 2023 - up 1851.91 % - -
Windtree Therapeutics Inc 4Q 2023 - - - -
X4 Pharmaceuticals Inc 3Q 2023 - - - -
Xtant Medical Holdings Inc 3Q 2023 up 68.26 % up 25.05 % - -
Zivo Bioscience Inc 4Q 2023 - flat 0 % - -
Zura Bio Limited 4Q 2023 - - up 7936.73 % -
Revenue
Biotechnology & Pharmaceuticals Industry

recorded in the 4. Quarter 2023 above average Revenue deterioration of -1.32 % year on year, Total Ranking #57 and ranking within sector #4.

Sequentially Revenues for Biotechnology & Pharmaceuticals Industry grew by 12.47 %.

More on Biotechnology & Pharmaceuticals Industry Revenue Growth




Income
Biotechnology & Pharmaceuticals Industry
in the 4. Quarter 2023 Net income contracted by -74.61 % year on year.

Sequentially, Biotechnology & Pharmaceuticals Industry turn into profitability. Net loss narrowed from previous quarter.

More on Biotechnology & Pharmaceuticals Industry Income Growth










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com